Skip to search formSkip to main contentSkip to account menu

Dopergin

Known as: Dopergine, Schering Brand 2 of Lisuride Maleate 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Lisuride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The effectiveness of vaginal lisuride in the treatment of hyperprolactinemia
Background: hyperprolactinemia is a disorder which may be represented clinically by one or more of the following: galactorrhea… 
2013
2013
Lisuride toxicity in a pediatric patient
Lisuride Maleate (Dopergin) is semi synthetic ergot alkaloid used for a variety of medical conditions. It is licensed for use in… 
1998
1998
[The method of treatment of functional evident hyperprolactinemia in sterile women].
OBJECTIVES AND DESIGN The aim of study was evaluation of three methods of treatment of functional, evident hyperprolactinemia in… 
1995
1995
Circadian plasma level profile of lisuride in rats and mice after continuous administration via the diet.
Lisuride (Dopergin, CAS 18016-80-3), a dopamine D2 agonist, was administered to male and female rats and mice continuously via… 
1991
1991
Supresión de Lactancia
In order to evaluate a new dopaminergic prolactin inhibitor: lisuride hydrogen maleate (Dopergin R), in suppression of lactation… 
1990
1990
The efficacy of lisuride in the treatment of hyperprolactinemic amenorrhea.
Thirteen women with hyperprolactinemic amenorrhea were treated with lisuride (Dopergin, Schering AG, Germany). The dosage of… 
1990
1990
[Terguride in hyperprolactinemia--experiences with 5 patients].
Hyperprolactinemia can successfully be treated by dopaminagonists such as bromocriptin or lisuride. About 10% of patients… 
1989
1989
[Treatment of hyperprolactinemia and acromegaly with lisuride].
17 hyperprolactinemic and 2 acromegalic patients, aged 19-73, and 47 and 59 years, respectively, were treated with Lisuride… 
1986
1986
Dopamine agonists in the treatment of hyperprolactinemia. Comparison between bromocriptine and lisuride.
27 patients (12 women and 15 men) with hyperprolactinemia were treated with the dopamine agonists lisuride (Dopergin) and… 
1986
1986
[Therapeutic strategies and tactics in parkinsonism].
The main medication is Madopar and Sinemet; various additives are able to reduce the Dopa dose in order to avoid various side… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)